Trials / Completed
CompletedNCT00539630
TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To describe the clinical response rate in two groups (Docetaxel plus cisplatin plus 5-FU, versus Cisplatin plus 5-FU) after 3 cycle of neoadjuvant chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel |
Timeline
- Start date
- 2002-11-01
- First posted
- 2007-10-04
- Last updated
- 2007-10-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00539630. Inclusion in this directory is not an endorsement.